Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

被引:18
作者
Wu, Fan [1 ]
Yuan, Xiao-Yi [1 ]
Huang, Wei-Shan [1 ]
Chen, Ying-Hua [1 ]
机构
[1] Tsinghua Univ, Immunol Lab, Dept Biol, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
Influenza virus; Combined vaccination; M2e; Split influenza vaccine; Heterosubtypic protection; PANDEMIC CONTROL STRATEGIES; EXTRACELLULAR DOMAIN; AVIAN INFLUENZA; A H5N1; VIRUS; IMMUNITY; PROTEIN; MICE; INFECTION;
D O I
10.1016/j.vaccine.2008.11.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is urgent need to develop influenza vaccines with broad-spectrum protection against the potential influenza pandemic. The extracellular domain of influenza M2 protein (M2e) is considered as an appropriate target to induce heterosubtypic protection. We investigated the immunity and protection induced by combined vaccination with synthetic M2e peptide and traditional split influenza vaccine. The combined vaccination was able to induce similar strain-specific hemagglutinin inhibition (HI) antibodies as vaccination of split virus alone. However, aluminum-adjuvant but not oil-in-water-emulsion adjuvant combined vaccination was able to induce high titers of anti-M2e antibodies and provoke M2e-specific T lymphocyte response. Furthermore, we found that the addition of M2e peptide greatly enhanced the cross-protective efficacy of split virus in aluminum adjuvant but slightly weakened the efficacy of vaccination in oil-in-water-emulsion adjuvant. Moreover, aluminum-adjuvant combined vaccination conferred complete cross-protection against heterosubtypic influenza virus. According to the results, we suggest that the M2e peptide should be added into split influenza vaccine in the preparation for the potential influenza pandemic. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 21 条
[1]   Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: Implications for pandemic control strategies [J].
Andreasen, Viggo ;
Viboud, Cecile ;
Simonsen, Lone .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (02) :270-278
[2]   Vaccination and antigenic drift in influenza [J].
Boni, Maciej F. .
VACCINE, 2008, 26 :C8-C14
[3]   A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus [J].
Carragher, Damian M. ;
Kaminski, Denise A. ;
Moquin, Amy ;
Hartson, Louise ;
Randall, Troy D. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (06) :4168-4176
[4]   The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice [J].
Cataldo, DM ;
VanNest, G .
VACCINE, 1997, 15 (16) :1710-1715
[5]   Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines [J].
Ernst, William A. ;
Kim, Hyung J. ;
Tumpey, Terrence M. ;
Jansen, Airan D. A. ;
Tai, Wendy ;
Cramer, Donald V. ;
Adler-Moore, Jill P. ;
Fujii, Gary .
VACCINE, 2006, 24 (24) :5158-5168
[6]   Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys [J].
Fan, JA ;
Liang, XP ;
Horton, MS ;
Perry, HC ;
Citron, MP ;
Heidecker, GJ ;
Fu, TM ;
Joyce, J ;
Przysiecki, CT ;
Keller, PM ;
Garsky, VM ;
Ionescu, R ;
Rippeon, Y ;
Shi, L ;
Chastain, MA ;
Condra, JH ;
Davies, ME ;
Liao, J ;
Emini, EA ;
Shiver, JW .
VACCINE, 2004, 22 (23-24) :2993-3003
[7]   Influenza pandemics, immune cross-reactivity, and pandemic control strategies [J].
Gioia, Cristiana ;
Agrati, Chiara ;
Castilletti, Concetta ;
Capobianchi, Maria R. ;
Martini, Federico .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (02) :294-295
[8]   Cross-subtype immunity against avian influenza in-persons recently vaccinated for influenza [J].
Gioia, Cristiana ;
Castilletti, Concetta ;
Tempestilli, Massimo ;
Piacentini, Paola ;
Bordi, Licia ;
Chiappini, Roberta ;
Agrati, Chiara ;
Squarcione, Salvatore ;
Lppolito, Giuseppe ;
Puro, Vincenzo ;
Capobianchi, Maria R. ;
Poccia, Fabrizio .
EMERGING INFECTIOUS DISEASES, 2008, 14 (01) :121-128
[9]   Influenza a vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity [J].
Jegerlehner, A ;
Schmitz, N ;
Storni, T ;
Bachmann, MF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5598-5605
[10]   Influenza and the work of the World Health Organization [J].
Kitler, ME ;
Gavinio, P ;
Lavanchy, D .
VACCINE, 2002, 20 :S5-S14